Skip to main content
COGT logo

COGT · Cogent Biosciences, Inc. · Executive Compensation

Track COGT — free
$26.72 -1.03 (-3.70%) At close · Nov 20
Market Cap
$4.65B
Shares
173.99M
Volume · Nov 20 2.13M Avg daily vol (3M) 2.08M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Andrew Robbins $27,762,684
Jessica Sachs $9,178,177
John Robinson $9,150,297
Cole Pinnow $8,839,548
John Green $8,546,329
Fiscal 2024
Executive Total
Andrew Robbins $4,917,890
Cole Pinnow $3,969,744
Jessica Sachs $1,832,714
John Robinson $1,807,431
John Green $1,747,767
Fiscal 2023
Executive Total
Andrew Robbins $7,898,772
Jessica Sachs $2,999,941
John Robinson $2,975,911
Fiscal 2022
Executive Total
Andrew Robbins $4,391,176
Jessica Sachs $1,907,927
John Robinson $1,869,151
Fiscal 2021
Executive Total
Jessica Sachs $3,809,193
John Robinson $3,473,113
Andrew Robbins $2,862,878
Fiscal 2020
Executive Total
Andrew Robbins $17,859,744
John Green $2,139,245
Charles Wilson $1,796,751
Jessica Sachs $1,189,457
Fiscal 2019
Executive Total
Charles Wilson $1,717,416

Executive changes

Person Change Filed
Todd Shegog Appointed 2023-06-07
Arlene M. Morris Appointed 2023-06-07
Chris Cain, Ph.D. Appointed 2023-06-07
Todd E. Shegog Appointed 2021-02-22

Leadership

Key facts CIK 1622229 CUSIP 19240Q201 13F (30d) 323 filings 300 filers Visit website Investor relations